SF3B5
Splicing factor 3B subunit 5
Also known as: MGC3133, SF3b10, SF3B5_HUMAN, Ysf3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BWJ5
- Gene
- SF3B5
- Ensembl
- ENSG00000169976
- Chromosome
- 6
- Canonical length
- 86 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Enables RNA binding activity and splicing factor binding activity. Involved in mRNA splicing, via spliceosome. Located in nucleoplasm. Part of U12-type spliceosomal complex and U2-type precatalytic spliceosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
86 residues, UniProt reviewed canonical sequence.
>Q9BWJ5|SF3B5
1 MTDRYTIHSQ LEHLQSKYIG TGHADTTKWE WLVNQHRDSY CSYMGHFDLL NYFAIAENES
61 KARVRFNLME KMLQPCGPPA DKPEENLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SF3B5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 238 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 238 nTPM
- choroid plexus: 214 nTPM
- liver: 185 nTPM
- adrenal gland: 176 nTPM
- kidney: 168 nTPM
- skeletal muscle: 154 nTPM
Single-cell type
- esophageal suprabasal cells: 671 nCPM
- esophageal basal cells: 564 nCPM
- esophageal apical cells: 433 nCPM
- gastric progenitor cells: 391 nCPM
- hofbauer cells: 383 nCPM
- decidual stromal cells: 383 nCPM
Immune cell
- classical monocyte: 379 nTPM
- plasmacytoid DC: 365 nTPM
- total PBMC: 364 nTPM
- myeloid DC: 327 nTPM
- intermediate monocyte: 278 nTPM
- non-classical monocyte: 258 nTPM
Brain region
- cerebellum: 89 nTPM
- white matter: 86 nTPM
- choroid plexus: 83 nTPM
- medulla oblongata: 83 nTPM
- pons: 82 nTPM
- thalamus: 81 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.07
- gnomAD pLI
- 0.58
- gnomAD missense Z
- 1.19
- DepMap mean gene effect
- -2.76
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA splicing, via spliceosome
- positive regulation of DNA-templated transcription
- regulation of DNA repair
- regulation of RNA splicing
- U2-type prespliceosome assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Splicing factor 3B subunit 5/RDS3 complex subunit 10
- Splicing factor 3B, subunit 5
- Splicing factor 3B subunit 10 (SF3b10)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SF3B5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SF3B5 as an antibody target. Whether an autoantibody or antibody against SF3B5 could matter depends on whether native SF3B5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SF3B5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SF3B5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...